Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction

IMPORTANCE: There is growing recognition that patients may respond differently to therapy and that the average treatment effect from a clinical trial may not apply equally to all candidates for a therapy. OBJECTIVE: To determine whether, among patients with an ischemic stroke or transient ischemic a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Neurol
Главные авторы: Kernan, Walter N., Viscoli, Catherine M., Dearborn, Jennifer L., Kent, David M., Conwit, Robin, Fayad, Pierre, Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Stuart, Amber, Young, Lawrence H.
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2017
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710663/
https://ncbi.nlm.nih.gov/pubmed/28975241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2136
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы